Search Results - "Waizbard, A."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis by Ungar, B., Mazor, Y., Weisshof, R., Yanai, H., Ron, Y., Goren, I., Waizbard, A., Yavzori, M., Fudim, E., Picard, O., Loebstein, R., Kopylov, U., Dotan, I., Chowers, Y., Eliakim, R., Ben‐Horin, S.

    Published in Alimentary pharmacology & therapeutics (01-06-2016)
    “…Summary Background Infliximab is effective as salvage therapy for patients with steroid refractory acute severe ulcerative colitis (UC). Although current data…”
    Get full text
    Journal Article
  2. 2
  3. 3

    P609 An IBD dermatology multidisciplinary clinic: A single tertiary centre experience by Levy, N, Matz, H, Maharshak, N, Waizbard, A

    Published in Journal of Crohn's and colitis (15-01-2020)
    “…Abstract Background Dermatologic manifestations of inflammatory bowel disease (IBD) are common and cause a significant burden on patients’ quality of life…”
    Get full text
    Journal Article